Clinical Trial Update: Randomized, Double-blind Study to Assess the Efficacy and Safety of α-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic Neuropathy [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind study comparing α-lipoic acid to BK-C-0701 in subjects with diabetic neuropathy has completed, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)
• BK-C-0701

Snippet

Sponsor: Bukwang Pharmaceutical | Conditions: Diabetic Neuropathies | Phase 3 | Status: COMPLETED